Cannabis Strategic Ventures, Inc. Completes Change of Control with Scopien Technologies
Legacy Series C Preferred Stock has been cancelled, while the parties target an audit and SEC registration filing within six months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cannabis Strategic Ventures (NUGS) closed its stock purchase transaction with Scopien Technologies, giving Scopien voting control through Series B Super Voting Preferred Stock.
Zameer Mulla became CEO and a director, replacing Richard C. Hawkins, who resigned all officer and director roles. The corporate name changed to Scopien Technologies in Nevada; a FINRA submission for the name and a new symbol is being prepared. The parties agreed to use best efforts to complete an audit and file an SEC registration statement within six months of the control change, toward SEC reporting status and an eventual national-exchange application. Scopien’s operating financials will form the combined company’s historical statements. Reported liabilities were approximately $491,000 at September 30, 2026; all legacy Series C Preferred Stock was cancelled.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointCompleted stock purchase transaction brings Scopien’s operating business into the combined company.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Audit and SEC registration filing targeted within six months of the control change, using best efforts.
- Minor pointAll legacy Series C Preferred Stock has been cancelled.
- Minor point. Forward-looking: it has not happened yet and may not happen.Independent directors are expected to be added as the company moves toward SEC reporting status.
- Minor point. Forward-looking: it has not happened yet and may not happen.Scopien expansion is planned, including growth in sales and partner channels.
Negative
- Major pointReported liabilities totaled approximately $491,000 at September 30, 2026. 37% of market cap
AI-generated analysis. How Rhea-AI works. Not financial advice.
OAKVILLE, Ontario, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cannabis Strategic Ventures, Inc. (OTC: NUGS) (“NUGS” or the “Company”) today announced that it has closed the transaction under the stock purchase agreement with Scopien Technologies Inc. (“Scopien”), a sovereign AI platform company based in Oakville, Ontario. With the closing, Scopien now holds voting control of the Company through the Company’s Series B Super Voting Preferred Stock.
Management and Board Changes
In connection with the change of control, Zameer Mulla has been appointed President, Chief Executive Officer, Treasurer, Secretary and a director of the Company, and Richard C. Hawkins has resigned from all officer and director positions. The Company expects to add independent directors as it moves toward SEC reporting status.
Audit and Registration Statement
The Company intends to engage a PCAOB-registered independent auditor to audit the financial statements of the Company and Scopien’s operating business. Because Scopien is the operating business, its financial statements will form the historical financial statements of the combined company. The parties have agreed to use their best efforts to complete the audit and file a registration statement with the SEC within six months of the change of control. Filing the registration statement is the first step toward SEC reporting status and an eventual application to list on a national securities exchange.
Name and Symbol Change
The Company has changed its corporate name to Scopien Technologies Inc. with the Nevada Secretary of State and is preparing its submission to FINRA to complete the name change and a new trading symbol. The Company will provide an update once all documentation has been submitted to FINRA, and will continue to report progress as each step is completed.
“We are excited to take this first big step into the public markets,” said Zameer Mulla, Chief Executive Officer of the Company and Scopien. “Becoming a public company gives us the platform to expand Scopien, grow our sales and partner channels, and bring sovereign AI to more businesses and governments. Our focus now is completing the audit and the registration statement, and we look forward to keeping shareholders updated as we build.”
Court Custodianship
This is the first strategic transaction for the Company since its court-supervised restoration, which was completed in April 2026. Total reported liabilities were approximately
About Scopien Technologies
Scopien Technologies Inc., based in Oakville, Ontario, builds sovereign AI that makes every business work as one. Scopien connects a company’s systems, including CRM, ERP, HR, payroll and helpdesk, into one operating platform and puts AI agents to work across it. Each customer runs its own instance in Scopien’s cloud, its own cloud or on-premises, so data stays inside its walls. Scopien serves mid-market companies, enterprises and government. For more information, visit www.scopien.com.
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures, Inc. is a Nevada corporation quoted on OTC Markets under the symbol “NUGS.” Following a court-supervised custodianship completed in April 2026, the Company completed its change of control with Scopien in November 2026.
Investor Contact
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the audit of the Company’s financial statements, the filing of a registration statement, the addition of independent directors, the change of the Company’s name and trading symbol, potential exchange listing, and Scopien’s business. Forward-looking statements can be identified by words such as “will,” “intends,” “anticipates,” “plans,” “expects” and similar expressions.
These statements are based on current expectations and are subject to significant risks and uncertainties, including: that the audit and registration statement may not be completed within the contemplated time frame or at all; that FINRA may not approve or may delay the name and symbol change; that Scopien’s platform may not achieve the customer adoption, market acceptance or growth its management anticipates; that additional funding may not be available on acceptable terms or at all; that securities remain subject to applicable former-shell-company resale restrictions under Rule 144(i); that exchange listing standards may not be met; and that legacy indebtedness and future financing may substantially dilute common stockholders. The super-voting preferred stock concentrates voting control in Scopien even if Scopien’s common equity ownership is diluted.
The safe harbor for forward-looking statements provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 is not available to the Company. The Company undertakes no obligation to update any forward-looking statement except as required by law.
This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any security.
Source: Cannabis Strategic Ventures, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who controls NUGS after the Scopien Technologies transaction?
Scopien Technologies holds voting control through the company’s Series B Super Voting Preferred Stock following completion of the stock purchase transaction.
When does NUGS plan to file its SEC registration statement?
The parties agreed to use best efforts to complete the audit and file an SEC registration statement within six months of the change of control. The company intends to engage a PCAOB-registered independent auditor to audit both the company and Scopien’s operating business.
What additional roles does Zameer Mulla hold at NUGS following the change of control?
Alongside CEO and director, Zameer Mulla was appointed President, Treasurer and Secretary of the company.